公开(公告)号：US20240350607A1

公开(公告)日：2024-10-24

申请号：US18687463

申请日：2022-08-30

Applicant: Vir Biotechnology, Inc.

Inventor： Ann M. Arvin ,  Julia Di Iulio ,  Janet L. Douglas ,  Emily Marshall ,  Leah B. Soriaga ,  Herbert W. Virgin

IPC: A61K39/04 ,  A61K39/00 ,  C07K14/35 ,  C12N5/0783 ,  C12N15/86

CPC classification number: A61K39/04 ,  A61K39/4611 ,  C07K14/35 ,  C12N5/0636 ,  C12N15/86 ,  A61K2039/5256 ,  C07K2319/42 ,  C12N2510/00 ,  C12N2710/16143

Abstract: The disclosure relates to tuberculosis antigens and vectors for delivering the antigens. The disclosure also relates to immunogenic compositions comprising the same, and their uses.

公开(公告)号：US20230210879A1

公开(公告)日：2023-07-06

申请号：US18082871

申请日：2022-12-16

Applicant: Vir Biotechnology, Inc. ,  Glaxo Wellcome UK Limited

Inventor： Dale R. Balce ,  Istvan Bartha ,  Johannes Grosse ,  Seungmin Hwang ,  Zachary Newby ,  Arnold Park ,  Leah B. Soriaga ,  Amalio Telenti ,  Winston C. Tse

IPC: A61K31/7072 ,  A61K31/427 ,  C07K16/18

CPC classification number: A61K31/7072 ,  A61K31/427 ,  C07K16/18

Abstract: The present disclosure relates to methods of inhibiting replication of a respiratory virus, and methods of treating or preventing a respiratory virus infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a N-glycosylation pathway inhibitor.